
Melissa L. McPheeters
Articles
-
Mar 31, 2024 |
psiquiatria.com | Melissa L. McPheeters |Elizabeth O’Connor
El trastorno por consumo de alcohol afecta a más de 28, 3 millones de personas en los Estados Unidos y se asocia con mayores tasas de morbilidad y mortalidad. Objetivo Comparar la eficacia y la eficacia comparativa de las terapias para el trastorno por consumo de alcohol. Fuentes de datos Se realizaron búsquedas en PubMed, la Biblioteca Cochrane, el Registro Cochrane Central d...
-
Mar 5, 2024 |
jamanetwork.com | Melissa L. McPheeters |Elizabeth O’Connor |Daniel E Jonas |Sean Riley
Pharmacotherapy for Alcohol Use Disorder—Reply Pharmacotherapy for Alcohol Use Disorder Melissa McPheeters, PhD, MPH; Elizabeth A. O’Connor, PhD; Sean Riley, MSc, MA; Sara M. Kennedy, MPH; Christiane Voisin, MSLS; Kaitlin Kuznacic, PharmD; Cory P. Coffey, PharmD; Mark D. Edlund, MD, PhD; Georgiy Bobashev, PhD; Daniel E.
-
Nov 7, 2023 |
jamanetwork.com | Melissa L. McPheeters |Elizabeth O’Connor |Sean Riley |Sara Kennedy
Key PointsQuestion Which pharmacotherapies are associated with improved outcomes for people with alcohol use disorder? Findings In this systematic review and meta-analysis that included 118 clinical trials and 20 976 participants, 50 mg/d of oral naltrexone and acamprosate were each associated with significantly improved alcohol consumption-related outcomes compared with placebo.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →